Financial Transaction:
Series D
Aderis Pharmaceuticals Inc
Currency
United States Dollar
Value in original currency
45,000,000
Value in USD
45,000,000
Lead investor
Investor | Country | Notes | |
---|---|---|---|
Paladin Capital GroupPrivate equity firm |
United States | Initial investment. |
Round participants
Investor | Country | Notes | |
---|---|---|---|
China Development Industrial Bank(CDIB)Private development financial institution in Taiwan. |
Taiwan | Initial investment. | |
International Biotechnology Trust PLC |
United Kingdom | Initial investment. | |
MDS Capital Corp |
Canada | Initial investment. | |
NeoMed Management AS |
Norway | Initial investment. | |
Perseus-Soros BioPharmaceutical Fund LP |
United States | Initial investment. | |
Sanderling Ventures |
United States | Initial investment. | |
Schroder Ventures KK |
Initial investment. | ||
Singapore Bio-Innovations |
Initial investment. | ||
Temasek Holdings (Pte) LtdSingapore's sovereign wealth fund. |
Singapore | Initial investment. |